In the development of antimicrobial agents, we designed and synthesized novel tetrazole derivatives. The structures of compounds 6a–f and 7a–f were characterized by IR, 1 H NMR, 13 C NMR, MS and elemental analysis. These compounds were tested for their antimicrobial activity against a series of strains Staphylococcus aureus, Bacillus subtilis, Escherichia coli , and Pseudomonas aeruginosa and for antifungal activity against the strains Candida albicans, Candida glabrata , and Candida tropicalis . Compounds 6e , 6f , 7a , and 7f exhibit potent antimicrobial activities compared to the reference drugs streptomycin and miconazole. Tetrazole derivatives 7a–f also inhibit biofilm formation and compound 7f exhibits best anti-biofilm activity with a biofilm inhibitory concentration (BIC) as low as 0.9 μ m .
New tetrazole-based pyrazole and pyrimidine derivatives were synthesized by an ultrasound irradiation method. All compounds were characterized by infrared spectroscopy (IR), 1 H nuclear magnetic resonance (NMR), 13 C NMR, mass spectrometry (MS) and elemental analysis and assessed in vitro for their efficacy as antimicrobial agents against four bacteria ( Staphylococcus aureus , Bacillus subtilis , Escherichia coli , Pseudomonas aeruginosa ) and two fungi ( Candida albicans , Aspergillus niger ). Compounds 8a , 8e , 9a , 9b and 9e show potent activity against the tested strains compared to the reference drugs chloramphenicol and clotrimazole.
2 August 2017 in Research on Chemical Intermediates